Kenya
· Delayed Price · Currency is KES NASE:BAT Statistics
Total Valuation
NASE:BAT has a market cap or net worth of KES 36.28 billion. The enterprise value is 34.48 billion.
| Market Cap | 36.28B |
| Enterprise Value | 34.48B |
Important Dates
The next estimated earnings date is Monday, February 17, 2025.
| Earnings Date | Feb 17, 2025 |
| Ex-Dividend Date | Sep 2, 2024 |
Share Statistics
NASE:BAT has 100.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 100.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.77% |
| Float | 40.00M |
Valuation Ratios
The trailing PE ratio is 7.43.
| PE Ratio | 7.43 |
| Forward PE | n/a |
| PS Ratio | 1.50 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 6.54 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.94, with an EV/FCF ratio of 6.22.
| EV / Earnings | 7.06 |
| EV / Sales | 1.43 |
| EV / EBITDA | 3.94 |
| EV / EBIT | 4.30 |
| EV / FCF | 6.22 |
Financial Position
The company has a current ratio of 1.98
| Current Ratio | 1.98 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 8.79 |
Financial Efficiency
Return on equity (ROE) is 34.32% and return on invested capital (ROIC) is 35.24%.
| Return on Equity (ROE) | 34.32% |
| Return on Assets (ROA) | 20.51% |
| Return on Invested Capital (ROIC) | 35.24% |
| Return on Capital Employed (ROCE) | 47.62% |
| Revenue Per Employee | 13.42M |
| Profits Per Employee | 2.71M |
| Employee Count | 1,800 |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.87% in the last 52 weeks. The beta is 0.24, so NASE:BAT's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -13.87% |
| 50-Day Moving Average | 361.66 |
| 200-Day Moving Average | 361.86 |
| Relative Strength Index (RSI) | 39.11 |
| Average Volume (20 Days) | 11,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NASE:BAT had revenue of KES 24.15 billion and earned 4.88 billion in profits. Earnings per share was 48.82.
| Revenue | 24.15B |
| Gross Profit | 10.64B |
| Operating Income | 8.02B |
| Pretax Income | 7.04B |
| Net Income | 4.88B |
| EBITDA | 8.73B |
| EBIT | 8.02B |
| Earnings Per Share (EPS) | 48.82 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 14.44B |
| Book Value Per Share | 144.44 |
| Working Capital | 5.34B |
Cash Flow
In the last 12 months, operating cash flow was 5.98 billion and capital expenditures -439.36 million, giving a free cash flow of 5.54 billion.
| Operating Cash Flow | 5.98B |
| Capital Expenditures | -439.36M |
| Free Cash Flow | 5.54B |
| FCF Per Share | 55.43 |
Margins
Gross margin is 44.08%, with operating and profit margins of 33.21% and 20.22%.
| Gross Margin | 44.08% |
| Operating Margin | 33.21% |
| Pretax Margin | 29.16% |
| Profit Margin | 20.22% |
| EBITDA Margin | 36.16% |
| EBIT Margin | 33.21% |
| FCF Margin | 22.95% |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 13.82%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 13.82% |
| Dividend Growth (YoY) | -12.28% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 116.76% |
| Buyback Yield | n/a |
| Shareholder Yield | 13.82% |
| Earnings Yield | 13.46% |
| FCF Yield | 15.28% |
Stock Splits
The last stock split was on March 13, 2000. It was a forward split with a ratio of 1.33333.
| Last Split Date | Mar 13, 2000 |
| Split Type | Forward |
| Split Ratio | 1.33333 |
Scores
NASE:BAT has an Altman Z-Score of 6.38.
| Altman Z-Score | 6.38 |
| Piotroski F-Score | n/a |